StockData
TEMNasdaqServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31

Tempus AI, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$64.34−0.38 (-0.59%)

Close on Oct 19, 2026

Market cap
$11.74M
P/E (TTM)
–
Dividend yield
–

About Tempus AI

Services-Computer Programming, Data Processing, Etc., SIC 7370

Tempus AI, Inc. develops technology and healthcare solutions centered on data-driven medicine. Through its operating areas, which include Diagnostics, Data and Applications, and AI Applications, the enterprise provides genomics testing services, insights, clinical trial solutions, and data licenses. The organization's offerings support healthcare providers, researchers, and life sciences entities by delivering testing capabilities alongside analytical data resources.

The company operates within domestic and international territories, conducting activities across regions that include Canada, Spain, and France, with property and legal jurisdiction spanning locations such as Washington and Pennsylvania. Tempus AI maintains its principal executive offices in Chicago, Illinois.

Summary of the business section of Tempus AI's latest annual report, written by StockData.

Company profile

Company

Legal name
Tempus AI, Inc.
Headquarters
Chicago, IL
Address
600 West Chicago Avenue, Suite 510 60654
Phone
(800) 976-5448
Website
tempus.com
Employees
3,800, Dec 31, 2025
Industry
Services-Computer Programming, Data Processing, Etc.
Incorporated in
Nevada
Fiscal year ends
December 31
Auditor
PricewaterhouseCoopers LLP, Chicago, Illinois

Stock & identifiers

Ticker
TEM
Exchange
Nasdaq
IPO date
Jun 17, 2024
Shares outstanding
180M, Jul 24, 2026
Public float
$11.00B, Jun 30, 2025
Filer category
Large accelerated filer
SEC CIK
1717115
CUSIP
88023B103
ISIN
US88023B1035
LEI
2549009LA0KWRAGQBX50
EIN
47-4903308

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Eric P. LefkofskyCEO and Chairman, Director46,804,573
Thomas Edward SchoenherrCEO, Diagnostics76,740
Ryan M. BartolucciChief Accounting Officer60,804
Andrew PolovinEVP, Chief Legal Officer135,189
Ryan FukushimaCEO, Data578,337
James William RogersChief Financial Officer106,024
Erik PhelpsEVP, Chief Admin. Officer85,466
David R. EpsteinDirector30,844
Jennifer A. DoudnaDirector25,266
Nadja WestDirector31,981
Scott GottliebDirector40,749
Wayne A.I. FrederickDirector30,749
Peter J. BarrisDirector121,424
Theodore LeonsisDirector88,180
Eric D. BelcherDirector35,457

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Eric Lefkofsky
$41.50M$67.93M$7.27M$147$63
FY2024
Eric Lefkofsky
$28.56M$28.63M$3.68M$84$87

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had more than 3,800 employees, of which 1,232 were technical and were engaged in product and engineering, and research and development.”

Corporate history

Events identified from SEC filings

DateEventDetails
Aug 31, 2026MergerRegistration of securities for a merger or exchange offer (S-4)
Jun 17, 2024IPOInitial public offering priced (424B4 prospectus)
Jun 11, 2024ListingRegistration of securities on an exchange (Form 8-A)
Dec 5, 2023Name changeName changed from Tempus Labs, Inc. to Tempus AI, Inc.